Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-13

FDA Approved: LEUCOVORIN CALCIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Leucovorin Calcium by Hikma Pharmaceuticals USA Inc., resulting in updated labeling for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leucovorin calcium (calcium folinate)

Snippet

SUPPL AP for LEUCOVORIN CALCIUM (LEUCOVORIN CALCIUM)